Inhibitory effects of ursodeoxycholic acid on the induction of nitric oxide synthase in vascular smooth muscle cells

被引:12
作者
Ma, J
Nakajima, T
Iida, H
Iwasawa, K
Terasawa, K
Oonuma, H
Jo, T
Morita, T
Imuta, H
Suzuki, J
Hirose, K
Okuda, Y
Yamada, N
Nagai, R
Omata, M
机构
[1] Univ Tokyo, Grad Sch Med, Dept Cardiovasc Resp Med & Gastroenterol, Bunkyo Ku, Tokyo 1138645, Japan
[2] Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 3050005, Japan
关键词
ursodeoxycholic acid; smooth muscle cell; aortic; coronary artery; nitric oxide (NO) synthase; lipopolysaccaride; interferon-gamma;
D O I
10.1016/S0014-2999(03)01373-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The expression of inducible nitric oxide synthase (iNOS) and the resultant increased nitric oxide production are associated with endotoxemia and atherosclerotic lesions observed in transplant hearts or balloon-injured artery. Ursodeoxycholic acid has been shown to have cardiovascular protective effects, such as inhibition of the development of transplant arteriosclerosis, but its mechanism remains unclear. Here, we investigated the effects of ursodeoxycholic acid on nitric oxide production and the expression of iNOS in vascular smooth muscle cells isolated from adult rat aorta and rabbit coronary artery. Nitrite released from cells in the culture medium was measured with the Griess reaction. iNOS mRNA and protein were measured by Northern and Western blot analyses. Treatment with ursodeoxycholic acid (30-1000 muM) significantly inhibited lipopolysaccharide plus interferon-gamma-induced nitric oxide production in a concentration-dependent manner, but ursodeoxycholic acid showed only small inhibitory effects on nitric oxide production that had already been induced by lipopolysaccharide plus interferon-gamma. Ursodeoxycholic acid by itself did not affect basal nitric oxide production. Ursodeoxycholic acid also suppressed lipopolysaccharide plus interferon-gamma-induced expression of iNOS mRNA and protein. Ursodeoxycholic acid had the most potent inhibitory effect among various kinds of bile acids examined, i.e. chenodeoxycholic acid, deoxycholic acid, cholic acid and conjugated bile acids such as tauroursodeoxycholic acid. These results suggest that ursodeoxycholic acid inhibits the induction of iNOS and then nitric oxide production in aortic and coronary artery smooth muscle cells, suggesting a possible mechanism for the cardiovascular protective effect of ursodeoxycholic acid under various pathophysiological conditions such as endotoxemia and atherosclerosis. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 39 条
[1]  
Akyurek LM, 1996, AM J PATHOL, V149, P1981
[2]   Cyclic GMP-dependent protein kinase expression in coronary arterial smooth muscle in response to balloon catheter injury [J].
Anderson, PG ;
Boerth, NJ ;
Liu, M ;
McNamara, DB ;
Cornwell, TL ;
Lincoln, TM .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (10) :2192-2197
[3]  
Bahrle S, 1998, J HEART LUNG TRANSPL, V17, P592
[4]  
Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424
[5]   URSODEOXYCHOLIC ACID INHIBITS GLUCAGON-INDUCED CAMP FORMATION IN HAMSTER HEPATOCYTES - A ROLE FOR PKC [J].
BOUSCAREL, B ;
GETTYS, TW ;
FROMM, H ;
DUBNER, H .
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 1995, 268 (02) :G300-G310
[6]  
Buttery LDK, 1996, LAB INVEST, V75, P77
[7]   Enhancement of endothelial nitric oxide production by chenodeoxycholic acids in patients with hepatobiliary diseases [J].
Chisaki, K ;
Nakajima, T ;
Iwasawa, K ;
Iida, H ;
Matsumoto, A ;
Tada, M ;
Komatsu, Y ;
Hirose, K ;
Miyamoto, K ;
Okuda, Y ;
Shiratori, Y ;
Goto, A ;
Hirata, Y ;
Nagai, R ;
Omata, M .
JAPANESE HEART JOURNAL, 2001, 42 (03) :339-353
[8]  
CIRILLO NW, 1994, AM J GASTROENTEROL, V89, P1447
[9]   Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque [J].
Depre, C ;
Havaux, X ;
Renkin, J ;
Vanoverschelde, JLJ ;
Wijns, W .
CARDIOVASCULAR RESEARCH, 1999, 41 (02) :465-472
[10]  
EARNEST DL, 1994, CANCER RES, V54, P5071